Please Wait

Applying Filters...

Abbvie Header week 48

Abbvie Header week 48

X

Details of Quotient Sciences's U.S. FDA Inspections. Original Data: FDA Inspection Database

Quotient Sciences

About, Contact Details

EVENTS

Webinars & Exhibitions

Webinars & Exhibitions

PRESENTATION(s)

Corporate Presentation, Oxilio & Quotient Announce Regulatory Approval for OXL001, Expansion of Facilities for Translational Pharmaceutics® Programs, Ensysce Biosciences & Quotient Announce a Partnership, Human ADME Studies, Bioanalytical Services, Translational Pharmaceutics®, Formulation Strategies for Poorly Soluble Molecules, Global Formulation Development & Manufacturing Capabilities, Commercial Manufacturing, Clinical Trial Manufacturing, Global Clinical Trial Supplies, GMP Certificate 2019, Financial Impact of Translational Pharmaceutics®, High Potency Handling, Project Management at Quotient Sciences, Pediatrics Services, Formulation Development, Clinical Pharmacology

VIDEO(s)

Corporate Video, Our Manifesto, Miami Clinical Pharmacology Facility

DIGITAL CONTENT

1 Interview #SpeakPharma, 99 News

DEVELOPMENTS

9 Drug(s) in Development

9 Drug(s) in Development

SERVICES

All Services, Analytical, Clinical Trials, API Manufacturing, Drug Product Manufacturing, API & Drug Product Development, Packaging

KEY SERVICES

Pharmacy Compounding Services, Pharmacy Compounding & Formulation Services, Formulation Development of Capsules, Development of Nasal Dosage Forms, Development of Pediatric Formulations, CDMO for Suspensions, Drug Substance Synthesis and Manufacturing

INSPECTIONS & REGISTRATIONS

6 FDA, 7 EDQM, 1 GDUFA

Quotient Sciences
FDA
Full Screen View